Transperineal Laser Ablation For Percutaneous Treatment Of Benign Prostatic Hyperplasia: A Feasibility Study.

Investigating the effectiveness and safety of SoracteLite™-transperineal percutaneous laser ablation (TPLA) in the treatment of patients with symptomatic benign prostatic hyperplasia (BPH) at 6 and 12 months follow-up.